Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
Clinical trial NCT05316129 · RECRUITING
Trial details
- NCT number
- NCT05316129
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2026-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.